These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8920779

  • 1. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
    Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Prato B, Prontera C, Facchini V, Genazzani AR.
    Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Gagetti O, Prontera C, Bianchi R, Facchini V.
    Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
    [Abstract] [Full Text] [Related]

  • 3. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 4. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T.
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in patients with cervical cancer.
    Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Prontera C, Facchini V, Genazzani A.
    Oncol Rep; 1996 Sep; 3(5):891-4. PubMed ID: 21594476
    [Abstract] [Full Text] [Related]

  • 6. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J, Zhao Q, Yao H.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
    [Abstract] [Full Text] [Related]

  • 7. Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
    Gao L, Bai L, Nan QZ, Yang XS, Chen K, Wen HP, Lai ZS, Bo L, Zhang YL, Zhang ZS.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):641-3. PubMed ID: 12376300
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M, Zwicker M, Villiger PM.
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J.
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [Abstract] [Full Text] [Related]

  • 10. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M, Iwai H, Naiki T, Ohnishi H, Muto Y, Moriwaki H.
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [Abstract] [Full Text] [Related]

  • 11. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
    Kawaguchi H, Ina Y, Ito S, Sato S, Sugiura Y, Tomita H, Ogisu N, Takada K, Yamamoto M, Morishita M, Yoshikawa K.
    Kekkaku; 1996 Mar; 71(3):259-65. PubMed ID: 8901228
    [Abstract] [Full Text] [Related]

  • 12. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
    Or R, Kalinkovich A, Nagler A, Weisman Z, Naparstek E, Weiss L, Hahn T.
    Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
    [Abstract] [Full Text] [Related]

  • 13. A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma.
    Brenne AT, Romstad LH, Gimsing P, Juliusson G, Turesson I, Romundstad P, Borset M, Sundan A, Waage A.
    Haematologica; 2004 May; 89(5):552-6. PubMed ID: 15136218
    [Abstract] [Full Text] [Related]

  • 14. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
    Maier B, Lehnert M, Laurer HL, Mautes AE, Steudel WI, Marzi I.
    Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.
    Itoh Y, Okanoue T, Ohnishi N, Sakamoto M, Nishioji K, Nakagawa Y, Minami M, Murakami Y, Kashima K.
    Am J Gastroenterol; 1999 May; 94(5):1332-40. PubMed ID: 10235215
    [Abstract] [Full Text] [Related]

  • 16. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
    Tur-Kaspa I, Maor Y, Weissenberg R, Madgar I, Aderka D, Dor J, Mashiach S, Wallach D.
    J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606
    [Abstract] [Full Text] [Related]

  • 17. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 18. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.
    Aderka D, Englemann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G.
    Cancer Res; 1991 Oct 15; 51(20):5602-7. PubMed ID: 1655258
    [Abstract] [Full Text] [Related]

  • 19. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Oct 15; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 20. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, Gusmano R, Borrone C, Pistoia V.
    J Rheumatol; 1998 Feb 15; 25(2):361-5. PubMed ID: 9489835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.